Lung Cancer

In an interview with Healio, Julia Rotow, MD, spoke about the importance of biomarker testing, the best methods to identify these biomarkers and new advances in personalized treatment options for patients

In this video, Andrew Ciupek, PhD, spoke with Healio about non-treatment-related presentations from at the World Conference on Lung Cancer.

In this video, Andrew Ciupek, PhD, discusses findings from the Alliance trial, IMpower010 and NADIM-2.

Andrew Ciupek, PhD, spoke with Healio about real-world barriers to clinical trial enrollment for patients with lung cancer in the United States.

Electronic noses that detect volatile organic compounds in exhaled breath have emerged as potential tools for cancer detection, but more investigation is needed before they can become part of the diagnostic workup, according to researchers.

Sotorasib prolonged PFS compared with standard chemotherapy for certain patients with non-small cell lung cancer, according to topline data released by the agent’s manufacturer.

Clinical trial accrual rates have dropped 20% since the start of the COVID-19 pandemic and staffing shortages have slowed progress in cancer research, according to the Society for Immunotherapy of Cancer.

In this video, Narjust Florez (Duma), MD, spoke with Healio about the prevalence of sexual dysfunction among women with lung cancer and the importance of including sexual health in oncology care.

In this video, Jia Luo, MD, spoke with Healio about results from her study on the safety of biopsies presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer.

Rates for CV admissions among patients with cancer has increased, according to a study published in the European Heart Journal Quality of Care & Clinical Outcomes.Primary CV admissions are highest among patients with hematological cancer with the most common cause of admission being heart failure, according to the study.